Paroxetine is NOT recommended for treating insomnia ("nightfall")
Paroxetine should not be used for insomnia treatment. The evidence consistently shows that paroxetine is not FDA-approved for insomnia, has poor efficacy for this indication, and actually worsens sleep architecture.
Why Paroxetine Should Be Avoided for Insomnia
Lack of FDA Approval and Guideline Support
- Paroxetine is not FDA-approved for insomnia 1
- The 2008 and 2017 American Academy of Sleep Medicine guidelines explicitly state that antidepressants like paroxetine are "employed in lower than antidepressant therapeutic dosages for the treatment of insomnia" but "are not FDA approved for insomnia and their efficacy for this indication is not well established" 2
- The 2017 AASM guideline does NOT recommend paroxetine for insomnia treatment 3
Negative Effects on Sleep Architecture
Research demonstrates that paroxetine actually disrupts sleep quality:
- Causes more frequent awakenings 4
- Reduces total sleep time 4
- Strongly suppresses REM sleep 4, 5
- Delays sleep onset when taken in the morning 4, 5
- Increases nocturnal wake time and stage 1 sleep 5
Limited and Contradictory Evidence
The only positive study was a small, open-label trial of 15 patients that showed subjective improvement but no objective improvement in sleep quantity on polysomnography 6. This weak evidence is insufficient to support clinical use.
What SHOULD Be Used Instead
First-Line Treatments (Based on 2017 AASM Guidelines)
For sleep onset insomnia:
- Zolpidem 10 mg at bedtime 3
- Zaleplon 10 mg at bedtime 3
- Triazolam 0.25 mg at bedtime 3
- Ramelteon 8 mg at bedtime 3
For sleep maintenance insomnia:
- Doxepin 3-6 mg at bedtime (NOT the higher antidepressant doses) 3
- Eszopiclone 2-3 mg at bedtime 3
- Suvorexant 10-20 mg at bedtime 3
- Temazepam 15 mg at bedtime 3
Important Caveats
- Low-dose doxepin (3-6 mg) is the only antidepressant with moderate-quality evidence for insomnia, but this is a hypnotic dose, not an antidepressant dose 3, 7
- Trazodone is specifically NOT recommended despite common use 3
- All medications should be used at the lowest effective dose for the shortest duration 2, 7
- Cognitive behavioral therapy for insomnia (CBT-I) is superior to pharmacotherapy for long-term outcomes 7
When Antidepressants Might Be Considered
The only scenario where paroxetine might be appropriate is when treating comorbid depression at full antidepressant doses (10-40 mg daily) 8, 1, where insomnia improvement would be secondary to depression treatment, not a primary indication.